Royal Bank of Canada’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-217,500
| Closed | -$21.6M | – | 7434 |
|
|
2019
Q3 | $21.6M | Hold |
217,500
| – | – | 0.01% | 1037 |
|
|
2019
Q2 | $20.1M | Sell |
217,500
-444,700
| -67% | -$42.2M | 0.01% | 1091 |
|
|
2019
Q1 | $62.5M | Buy |
662,200
+405,600
| +158% | +$35.5M | 0.03% | 485 |
|
|
2018
Q4 | $16.4M | Buy |
256,600
+89,300
| +53% | +$6.59M | 0.01% | 1122 |
|
|
2018
Q3 | $15M | Sell |
167,300
-18,400
| -10% | -$1.63M | 0.01% | 1324 |
|
|
2018
Q2 | $14.7M | Sell |
185,700
-41,200
| -18% | -$3.42M | 0.01% | 1272 |
|
|
2018
Q1 | $20.2M | Buy |
226,900
+220,400
| +3,391% | +$21.2M | 0.01% | 1083 |
|
|
2017
Q4 | $678K | Hold |
6,500
| – | – | ﹤0.01% | 3556 |
|
|
2017
Q3 | $948K | Buy |
6,500
+1,000
| +18% | +$136K | ﹤0.01% | 3259 |
|
|
2017
Q2 | $715K | Buy |
5,500
+3,200
| +139% | +$392K | ﹤0.01% | 3373 |
|
|
2017
Q1 | $286K | Sell |
2,300
-45,800
| -95% | -$5.48M | ﹤0.01% | 4105 |
|
|
2016
Q4 | $5.57M | Sell |
48,100
-6,800
| -12% | -$757K | ﹤0.01% | 1881 |
|
|
2016
Q3 | $5.74M | Sell |
54,900
-26,200
| -32% | -$2.84M | ﹤0.01% | 1819 |
|
|
2016
Q2 | $8M | Sell |
81,100
-27,900
| -26% | -$2.89M | ﹤0.01% | 1601 |
|
|
2016
Q1 | $10.9M | Buy |
109,000
+29,600
| +37% | +$3.05M | 0.01% | 1327 |
|
|
2015
Q4 | $9.51M | Buy |
79,400
+43,400
| +121% | +$5.02M | 0.01% | 1463 |
|
|
2015
Q3 | $3.89M | Sell |
36,000
-2,000
| -5% | -$248K | ﹤0.01% | 1737 |
|
|
2015
Q2 | $4.4M | Buy |
38,000
+26,000
| +217% | +$2.97M | ﹤0.01% | 1705 |
|
|
2015
Q1 | $1.38M | Sell |
12,000
-24,500
| -67% | -$2.93M | ﹤0.01% | 2596 |
|
|
2014
Q4 | $4.08M | Buy |
36,500
+13,500
| +59% | +$1.42M | ﹤0.01% | 1804 |
|
|
2014
Q3 | $2.18M | Buy |
23,000
+22,000
| +2,200% | +$1.99M | ﹤0.01% | 2238 |
|
|
2014
Q2 | $86K | Sell |
1,000
-35,000
| -97% | -$2.66M | ﹤0.01% | 4623 |
|
|
2014
Q1 | $2.51M | Buy |
36,000
+20,000
| +125% | +$1.58M | ﹤0.01% | 2087 |
|
|
2013
Q4 | $1.35M | Sell |
16,000
-129,000
| -89% | -$10.2M | ﹤0.01% | 2593 |
|
|
2013
Q3 | $11.2M | Buy |
+145,000
| New | +$10.2M | 0.01% | 1081 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Royal Bank of Canada's CELG Position: Q4 2019 in Review
Royal Bank of Canada sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 915,127 shares — an estimated $90.9M sold.
Royal Bank of Canada first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $396M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Royal Bank of Canada reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Royal Bank of Canada sold 915,127 Celgene Corp shares in Q4 2019, an estimated $90.9M.
- Royal Bank of Canada first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Royal Bank of Canada's Celgene Corp position peaked at $396M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.